According to @mcuban, healthcare economics hinge on three trading-relevant questions: what is the price, who pays, and who bears financial risk when patients cannot pay (source: @mcuban on X). According to @mcuban, traditional insurance companies resist bearing true risk while reinsurance carriers assume the real exposure, placing the sector’s risk premium squarely on reinsurers (source: @mcuban on X). According to @mcuban, opaque pricing enables vertically integrated players to game economics, making cost discovery essential before any durable plan—whether universal care or alternatives—can be designed, which keeps risk quantification and margin visibility uncertain across managed care, PBMs, and reinsurance exposures (source: @mcuban on X).